Niranjan Kameswaran | Senior Vice President, Strategy |
Mary Reumuth | Chief Financial Officer |
Mark Iwicki | Chairman, President & Chief Executive Officer |
Kim Brazzell | Chief Medical Officer |
Todd Bazemore | Chief Operating Officer |
Liana Moussatos | Wedbush Securities |
Chris Neyor | J.P. Morgan |
Esther Rajavelu | Oppenheimer & Co. |
Biren Amin | Jefferies LLC |
Yi Chen | H.C. Wainwright & Co. |
* |
Good morning and welcome to the Kala Pharmaceuticals' Fourth Quarter and Full-Year 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Following the management's prepared remarks, a Q&A session will be held.
As a reminder, this call is being recorded.
I would now like to turn the call over to Niranjan Kameswaran, Senior Vice President of Strategy for Kala Pharmaceuticals.